Company Quick10K Filing
Novo Nordisk
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
20-F 2018-12-31 Annual: 2018-12-31
20-F 2017-12-31 Annual: 2017-12-31
20-F 2016-12-31 Annual: 2016-12-31
20-F 2015-12-31 Annual: 2015-12-31

Novo Nordisk Financials

-

NVO Metrics, Comps, Filings


Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Stockholders' Equity

Income Statement ($ Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($ Quarter)

Operating, Investing, Financing

Comps ($ TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Advaxis (ADXS) 5,774,655,000 56,133,000,000 6,864,000,000 22,012,000,000 0 1,812,000,000 3,429,000,000 -35,980,346,000
Tonix Pharmaceuticals Holding (TNXP) 8,683,498,000 15,008,000,000 2,186,000,000 0 0 -23,639,000,000 -23,595,000,000 -3,566,503,000
Delmar Pharmaceuticals (DMPI) 3,295,606,000 4,037,255,000 2,069,725,000 0 0 8,048,221,000 8,048,221,000 -423,152,000
Diffusion Pharmaceuticals (DFFN) 1,924,249,000 18,929,138,000 2,751,552,000 0 0 -17,533,875,000 -17,962,488,000 -6,448,493,000
Phibro Animal Health (PAHC) 1,272,017,000 726,671,000,000 510,656,000,000 624,112,000,000 264,624,000,000 54,713,000,000 109,193,000,000 174,989,017,000
OHR Pharmaceutical (OHRP) 10,128,708,000 8,692,910,000 751,701,000 0 0 -9,529,394,000 -8,750,408,000 8,704,111,000
Therapix Biosciences (TRPX) 0 4,560,000,000 0 0 0 0 -1,518,001,000
Grifols (GRFS) 12,477,046,000,000 7,780,442,000,000 0 0 0 0 -592,178,002,000
Novo Nordisk (NVO)
Bioblast Pharma (ORPN) 39,270,242,000 11,034,000,000 1,328,000,000 0 0 -3,073,000,000 -3,073,000,000 29,534,241,000
Trillium Therapeutics (TRIL) 55,459,000,000 13,858,000,000 0 0 0 0 -1,000
Kiniksa Pharmaceuticals (KNSA) 308,137,000,000 32,940,000,000 0 0 -169,998,000,000 -170,154,000,000 -287,447,002,000
AstraZeneca (AZN) 60,651,000,000,000 46,607,000,000,000 0 0 0 0 -893,000,002,000
Immtech Pharmaceuticals (IMMP)
Zomedica Pharmaceuticals (ZOM) 9,479,407,000 1,796,803,000 0 0 -24,413,295,000 -24,124,452,000 -5,822,150,000
VTV Therapeutics (VTVT) 9,072,000,000 21,914,000,000 10,646,000,000 0 -6,924,000,000 -4,119,000,000 5,934,999,000
Nabriva Therapeutics (NBRV) 678,757,588,000 83,645,000,000 40,240,000,000 3,486,000,000 0 -125,573,000,000 -123,455,000,000 629,163,588,000
Affimed (AFMD) 116,174,000,000 0 0 0 0 -1,000
Zealand Pharma (ZEAL)
Intec Pharma (NTEC) 46,860,000,000 11,751,000,000 0 0 -20,665,000,000 -20,593,000,000 -20,796,002,000

Balance Sheet ($)
Cash
Accounts Receivable
Inventory
PP&E
Assets
Accounts Payable
Long-Term Debt
Liabilities
Stockholders' Equity
Income Statement ($)
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax
Net Income
Cash Flow ($)
Cash Operating
Cash Investing
Cash Financing